CareTrust REIT Remains A Strong Buy After Q1 Results, Driving The Growth Thesis

CareTrust REIT maintains a strong buy rating, supported by robust portfolio growth and favorable senior care demand trends. CTRE demonstrates impressive EBITDA margins above 86%, with analyst consensus forecasting FFO growth this year and next. The REIT outperforms peers in return on equity and has considerable geographic diversification, with notable expansion into the UK market.